The IL-1β exhibited an AUC of 0.72 with 72.5% sensitivity and 70% specificity, at a cut-off point of 1527.25 (pg/mL), while IL-18 had an AUC of 0.78 with 77.5% sensitivity and 72.7% specificity, at a cut-off point of 19.645 (ng/L).<h4>Conclusions</h4>IL-1β and IL-18 levels were increased remarkably in mTBI patients and exhibited fair potential as biomarkers for the diagnosis and prognosis of TBI. The gene discussed is IL18; the disease is concussion.